HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Zoledronic acid was initially used for bone metastases in various malignancies. However, it is unknown whether hepatic arterial infusion chemotherapy combined with zoledronic acid can improve overall survival of unresectable hepatocellular carcinoma.
Epistemonikos ID: 5be2517676ecc0c5d2459aed77ec9573db00d5ad
First added on: Feb 19, 2024